Finance

Lists
Why is 6472 down 9.97%?
Dive Deeper
6472:TPE
Bora Pharmaceuticals Co Ltd
NT$280.00
-9.97%
(-31.00) 1D
ኖቬም 20, 1:24:15 ከሰዓት ጂ ኤም ቲ+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6472...
Open
NT$309.50
High
NT$309.50
Low
NT$280.00
Mkt. cap
35.85 ቢ
Avg. vol.
814.06 ሺ
Volume
1.65 ሚ
P/E ratio
23.61
52-wk high
NT$633.00
52-wk low
NT$280.00
EPS
NT$11.86
No. of employees
36
Open
NT$309.50
High
NT$309.50
Low
NT$280.00
Mkt. cap
35.85 ቢ
Avg. vol.
814.06 ሺ
Volume
1.65 ሚ
P/E ratio
23.61
52-wk high
NT$633.00
52-wk low
NT$280.00
EPS
NT$11.86
No. of employees
36
News stories
From web sources and news partners
Adam Feldman | Substack
Adam Feldman | Substack
·
ከ11 ሰዓቶች በፊት
Inside the Federal Litigation of Five S&P 500 Giants
RealMoney Pro
RealMoney Pro
·
ከ6 ሰዓቶች በፊት
Anthropic Pops, but the S&P 500 Drops
The Harvard Law School Forum on Corporate Governance
The Harvard Law School Forum on Corporate Governance
·
ከ16 ሰዓቶች በፊት
Board Practices and Composition in the Russell 3000 and S&P 500
About Bora Pharmaceuticals Co Ltd
CEOBobby Sheng
Employees36
Founded2007
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
13 ኖቬም 2026
Fiscal period
Q3 2026
NT$4.66 / NT$5.23
-10.96%miss
Revenue / Est. (TWD)
6.45 ቢ / 6.28 ቢ
+2.79%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
4.86 ቢ
4.00 ቢ
5.89 ቢ
6.45 ቢ
Cost of goods sold
3.09 ቢ
2.56 ቢ
3.46 ቢ
3.92 ቢ
Cost of revenue
3.09 ቢ
2.56 ቢ
3.46 ቢ
3.92 ቢ
Research and development expenses
181.25 ሚ
167.93 ሚ
190.74 ሚ
182.11 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.03 ቢ
866.09 ሚ
1.25 ቢ
1.26 ቢ
Operating expense
1.22 ቢ
1.04 ቢ
1.44 ቢ
1.44 ቢ
Total operating expenses
4.30 ቢ
3.59 ቢ
4.90 ቢ
5.36 ቢ
Operating income
556.34 ሚ
407.24 ሚ
986.64 ሚ
1.09 ቢ
Other non operating income
15.19 ሚ
24.01 ሚ
-15.28 ሚ
14.83 ሚ
EBT including unusual items
809.67 ሚ
221.15 ሚ
813.10 ሚ
802.18 ሚ
EBT excluding unusual items
375.02 ሚ
222.24 ሚ
788.94 ሚ
802.18 ሚ
Income tax expense
381.93 ሚ
174.25 ሚ
205.59 ሚ
150.36 ሚ
Effective tax rate
47.17%
78.79%
25.28%
18.74%
Other operating expenses
1.24 ሚ
1.37 ሚ
-
-
Net income
331.76 ሚ
25.84 ሚ
555.76 ሚ
611.94 ሚ
Net profit margin
6.83%
0.65%
9.44%
9.48%
Earnings per share
2.78
0.20
4.24
4.66
Interest and investment income
10.49 ሚ
6.25 ሚ
11.16 ሚ
-
Interest expense
-122.01 ሚ
-113.73 ሚ
-124.33 ሚ
-187.91 ሚ
Net interest expenses
-111.52 ሚ
-107.48 ሚ
-113.17 ሚ
-187.91 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
784.95 ሚ
634.54 ሚ
1.27 ቢ
1.60 ቢ
Gain or loss from assets sale
1.32 ሚ
63.00 ሺ
2.00 ሺ
2.00 ሺ
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች